Algert Global LLC Cti Biopharma Corp Transaction History

Algert Global LLC

  • $3.72 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 01, 2019
SELL
$0.73 - $2.19 $247,724 - $743,174
-339,349 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$1.72 - $5.24 $208,680 - $635,748
121,326 Added 55.65%
339,349 $733,000
Q2 2018

Aug 02, 2018
BUY
$3.81 - $5.26 $830,667 - $1.15 Million
218,023 New
218,023 $1.09 Million

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email